| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/13/2008 | WO2007136302A8 Active substances, pharmaceutical composition and a method for the production and use thereof |
| 03/13/2008 | WO2007127635A3 Diketo-piperazine and piperidine derivatives as antiviral agents |
| 03/13/2008 | WO2007112753A3 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 03/13/2008 | WO2007079391A3 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 03/13/2008 | US20080064753 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 03/13/2008 | US20080064752 Nonhygroscopic photosensitizing agents; sulphonate, hydrobromide, sulfate, nitrate and/or phosphate derivatives; diagnosing skin disorders |
| 03/13/2008 | US20080064746 Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases |
| 03/13/2008 | US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064711 Composition for treating oral cavity and Mucousal infections |
| 03/13/2008 | US20080064658 Use of Isomaltooligosaccharides to Decrease Abdominal Fat |
| 03/13/2008 | US20080064657 For birds and mammals by oral administration; probiotics; non-competitive inhibitors of alpha -glucosidase; fermenting sucrose in the presence of maltose |
| 03/13/2008 | US20080064655 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B |
| 03/13/2008 | US20080064647 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active |
| 03/13/2008 | US20080064645 A carbohydrate linked to a fluorophore through a 2-amido-2-(1-hydroxyalkyl)ethoxy linkage; inhibition of caveolar endocytosis, plasma membrane microdomain formation, virus binding and infection, transmembrane signaling, and integrin function in cells; anticarcinogenic and antiinflammatory agents |
| 03/13/2008 | US20080063735 Therapeutic aromatherapy spray; essential oils, lemon oil, orange oil, lavender oil, grapefruit oil, chamomile oil enhances mood; volatile liquid carrier readily evaporates on skin; antimicrobial agent, an anesthetic, a surfactant, a coloring agent, alkyltriethanolammonium chloride, benzalkonium chloride |
| 03/13/2008 | US20080063729 Sprayed dispersion dressing of a silver ions in optically transparent to visible and near infrared spectrum imogolite, allophone-like matrix; light radiation treatment of wounds without removing the dressing |
| 03/13/2008 | US20080063722 Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
| 03/13/2008 | US20080063692 Isomaltooligosaccharides to Inhibit Avian Pathogenic Intestinal Bacteria |
| 03/13/2008 | US20080063665 vaccine contains two or more serotypes of meningococcus; membrane proteins, conjugated capsular saccharide; immunization against disease |
| 03/13/2008 | US20080063663 immunizing a cat with vaccine against a hemorrhagic feline calicivirus (hFCV); veterinary medicine |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063661 treating a wart with a fusion protein comprising (1) a heat shock protein and (2) a human papilloma virus (HPV) protein; Mycobacterium bovis heat shock protein; HPV is an E7 protein; cervical dysplasia, anal cancer, anal dysplasia |
| 03/13/2008 | US20080063649 pretreatment step involving a highly specific and high affinity neutralizing antibody |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063624 administering compounds which bind to the chemokine receptors, such as 1,1'-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane, optionally with colony stimulating factors, to effect regeneration of dead myocardium |
| 03/13/2008 | US20080063618 a mixture of zinc pyrithione in combination with water soluble zinc containing materials such as zinc oxide and anionic, cationic, nonionic, amphoteric or zwitterionic surfactants, used as antidandruff agents with improved efficacy |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | DE102006039615A1 Esterelongationsverfahren zum sequenzgesteuerten Aufbau alternierender Peptid-Peptoid-Polymere (Peptid-Peptoid-Polymere) Esterelongationsverfahren for the sequence-structure-controlled alternating peptide-peptoid polymers (peptide-peptoid polymers) |
| 03/13/2008 | DE10107659B4 Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin Mucoadhesive disintegratable pharmaceutical preparation for drug delivery in veterinary and human medicine |
| 03/13/2008 | CA2663091A1 Modulators of interleukin-1 receptor-associated kinase |
| 03/13/2008 | CA2662628A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/12/2008 | EP1897948A1 Mammalian transforming growth factor beta 9 |
| 03/12/2008 | EP1897883A2 Cationic porphyrin derivatives as antibacterial agents |
| 03/12/2008 | EP1897880A1 1,3-benzothiazinone derivative and use thereof |
| 03/12/2008 | EP1897555A2 Supplemented OMV vaccine against meningococcus |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896601A1 Bioactive agents produced by submerged cultivation of a basidiomycete cell |
| 03/12/2008 | EP1896477A1 Aspartyl protease inhibitors |
| 03/12/2008 | EP1896452A2 N-formyl hydroxylamine compounds |
| 03/12/2008 | EP1896066A2 Immunogenic composition |
| 03/12/2008 | EP1896065A2 Process for manufacturing vaccines |
| 03/12/2008 | EP1896061A2 Immunogenic composition |
| 03/12/2008 | EP1896001A1 N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids |
| 03/12/2008 | EP1745780A4 Medicinal preparation |
| 03/12/2008 | EP1705182A4 Antitumoral and antiviral peptides |
| 03/12/2008 | EP1697345B1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 03/12/2008 | EP1506317B1 Marker molecules associated with lung tumors |
| 03/12/2008 | EP1450775B1 C-kit inhibitors for treating bacterial infections |
| 03/12/2008 | EP1427395B1 Stabilization of active agents by formulation into nanoparticulate form |
| 03/12/2008 | EP1411986B1 Composition comprising epigallocatechin gallate |
| 03/12/2008 | EP1292611B1 Glycopeptide carboxy-saccharide derivatives |
| 03/12/2008 | EP1265648B1 NOVEL collagen-BASED MATERIAL WITH IMPROVED PROPERTIES FOR USE IN HUMAN AND VETERINARY MEDICINE AND THE METHOD OF MANUFACTURING SUCH |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP0972048B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101142226A Tricyclic-nucleoside prodrugs for treating viral infections |
| 03/12/2008 | CN101139390A Pig gamma interferon and encoding genes and use thereof |
| 03/12/2008 | CN101139363A M-crystal system of adefovir dipivoxil ester and preparation method and medicine application |
| 03/12/2008 | CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
| 03/12/2008 | CN101139304A Conjugated dienamides and uses thereof |
| 03/12/2008 | CN101138628A Chinese medicine for treating common cold in any season |
| 03/12/2008 | CN101138624A Chinese medicine for treating baraquet |
| 03/12/2008 | CN101138618A Chinese medicine for treating tuberculosis fever |
| 03/12/2008 | CN101138617A Multiple-effect paste for activating blood circulation and removing stasis |
| 03/12/2008 | CN101138590A Use of medicinal fatheadtree leaf in the preparation of antimicrobial anti-inflammation medicament |
| 03/12/2008 | CN101138580A Chinese medicine preparation and preparation method thereof |
| 03/12/2008 | CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
| 03/12/2008 | CN101138561A Application of 5,6,7-trihydroxy flavone in the preparing of medicine for restraining bacterium |
| 03/12/2008 | CN101138560A Nitrofuran gelling agent and method of preparing the same |
| 03/12/2008 | CN101138557A Chlorhexidine acetate partial film forming gel composition and uses thereof |
| 03/12/2008 | CN101138556A Terbinafine or its salt film forming gel composition and uses thereof |
| 03/12/2008 | CN101138552A Preparation method of almecillin V potassium granular formulation |
| 03/12/2008 | CN100374563C Attenuated pestiviruses |
| 03/12/2008 | CN100374464C Anti-SARS monoclonal antibody, encoding sequence and application thereof |
| 03/12/2008 | CN100374463C Method for preparing nanometer realgar gel and nanometer realgar with biomacromolecule template to regulate shape and particle thereof |
| 03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
| 03/12/2008 | CN100374148C Oral liquid for preventing and treating diarrhea |
| 03/12/2008 | CN100374118C Drip pill agent containing adefovir divoxil and its preparing method |
| 03/12/2008 | CN100374114C Antibiotic compositions for treatment of the eye, ear and nose |
| 03/12/2008 | CN100374110C Local preparation containing poloxamer and other microbe killing agent and applicator |
| 03/12/2008 | CN100374104C Scutellaria alkyl amine granules and its preparation method |
| 03/12/2008 | CN100374099C Antimicrobial composition |
| 03/11/2008 | US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342026 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide |
| 03/11/2008 | US7342005 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; favourable duration of action; infections |
| 03/11/2008 | US7342000 Semisynthetic macrolide antibiotics of the azalide series |
| 03/11/2008 | US7341993 Cross-linked glycopeptide—cephalosporin antibiotics |
| 03/11/2008 | US7341988 Method of treating influenza with geranyl-geranyl acetone |
| 03/11/2008 | US7341744 Administering aqueous soluble proanthocyanidin polymer isolated from a Croton species or a Calophyllum species; protective coating for oral administration |
| 03/11/2008 | US7341729 Recombinant parainfluenza virus expression systems and vaccines |
| 03/11/2008 | US7341728 Internalisation of virus into cells |
| 03/11/2008 | US7341725 Structural proteins of fish pancreatic disease virus and uses thereof |
| 03/11/2008 | US7341723 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide |
| 03/11/2008 | CA2468929C Medical adhesive and medical covering agent using ultraviolet ray curable chitosan derivative |
| 03/11/2008 | CA2358022C Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |